Acute anterior ST elevation Myocardial infarction treated with primary PCI. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: Patients with Anterior ST-segment elevation acute myocardial infarction treated with primary PCI receiving Crataegus monogyna extract tablet (400 mg, prepared by Di
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with Anterior ST-segment elevation acute myocardial infarction according to the American College of Heart criteria Consent to admission to the study Age more than 18 years old
Exclusion criteria
Exclusion criteria: Kidney failure under hemodialysis Severe liver failure with liver enzymes three times more than normal History of using medicinal products containing Crataegus monogyna extract History of heart disease and important valvular diseases in recent echocardiography
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left ventricle ejection fraction. Timepoint: At the beginning of the study and after 40 days of treatment. Method of measurement: Echocardioghraphy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in pulmonary artery pressure. Timepoint: At the beginning of the study and after 40 days of treatment. Method of measurement: Echocardioghraphy.;Left ventricular end-diastolic volume. Timepoint: At the beginning of the study and after 40 days of treatment. Method of measurement: Echocardioghraphy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Vafa Baradaran Rahimi
Mashhad University of Medical Sciences
Outcome results
None listed